文献速递流行病学与生物统计真实世界研究与卫生经济

肾衰竭风险方程在英國基层医疗中预测终末期肾病的外部验证与临床影响投影队列研究

The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
PubMed 文献 · PLoS Med · 2019-11-06

KFRE区分度优秀(2年C统计量0.932,5年0.924),但低估低风险组风险;采用5年ESRD风险≥5%和/或ACR≥70 mg/mmol的转诊标准可减少不必要转诊并在更年轻、eGFR更高时转诊将发生ESRD者。

要点

  • KFRE在基层医疗队列中对2年和5年ESRD预测区分度优秀(C统计量分别为0.932和0.924)。
  • KFRE低估低风险组(<20%)风险,降低基线风险可改善校准但导致高风险组部分低估。
  • 基于5年ESRD风险≥5%和/或ACR≥70 mg/mmol的转诊标准可减少不必要转诊并提前转诊将发生ESRD者。

核心结论

  • 在该队列中,重新校准的KFRE准确预测了基层医疗中2年和5年ESRD风险。
  • 将其引入基层医疗用于转诊至二级肾脏服务可能减少不必要转诊,并使将发生ESRD者更早转诊。
  • 在临床实施所建议的转诊标准和临床影响投影前,需要在更多样化队列中进一步验证。

研究设计与样本

  • 外部验证与临床影响投影队列研究,纳入2004年12月1日至2016年11月1日期间至少2次间隔超过90天的CKD-EPI eGFR值<60 ml/min/1.73 m2且有尿ACR或蛋白肌酐比测量的个体。
  • 队列包括来自630504名成人实践人群的35539名(5.6%)个体,女性57.5%,平均年龄75.9岁,中位CKD-EPI eGFR 51 ml/min/1.73 m2,中位ACR 3.2 mg/mmol。
  • 中位随访时间4.7年(IQR 2.8至6.6)。

主要发现

  • 2年内发生176例(0.50%)ESRD事件,5年内发生429例(1.21%)ESRD事件。
  • 2年ESRD预测的C统计量为0.932(95% CI 0.909至0.954),5年为0.924(95% CI 0.909至0.938)。
  • KFRE低估低风险组(<20%)风险;降低模型基线风险改善了2年和5年低风险组的校准,但导致高风险组部分低估。
  • 与现行标准相比,基于KFRE计算的5年ESRD风险≥5%和/或ACR≥70 mg/mmol的转诊标准减少了未发生ESRD但符合转诊条件的人数。
  • 该转诊标准增加了将发生ESRD者符合转诊条件的可能性,并使后者在更年轻和eGFR更高时被转诊。

关键数值与推荐

  • KFRE使用年龄、性别、尿白蛋白肌酐比(ACR)和估算肾小球滤过率(eGFR)4个变量预测2年和5年ESRD风险。
  • 本研究中评估的转诊标准为KFRE计算的5年ESRD风险≥5%和/或ACR≥70 mg/mmol。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为,将重新校准的KFRE引入基层医疗用于转诊至二级肾脏服务可能减少不必要转诊,并使将发生ESRD者更早转诊。
  • 作者指出,在临床实施所建议的转诊标准和临床影响投影前,需要在更多样化队列中进一步验证。

局限性

  • 本研究的主要局限性是队列来自英國一个地区,因此可能不能代表其他国家的基层医疗CKD诊疗。
  • 在临床实施所建议的转诊标准和临床影响投影前,需要在更多样化队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Kidney Failure Risk Equation (KFRE) uses the 4 variables of age, sex, urine albumin-to-creatinine ratio (ACR), and estimated glomerular filtration rate (eGFR) in individuals with chronic kidney disease (CKD) to predict the risk of end stage renal disease (ESRD), i.e., the need for dialysis or a kidney transplant, within 2 and 5 years. Currently, national guideline writers in the UK and other countries are evaluating the role of the KFRE in renal referrals from primary care to secondary care, but the KFRE has had limited external validation in primary care. The study's objectives were therefore to externally validate the KFRE's prediction of ESRD events in primary care, perform model recalibration if necessary, and assess its projected impact on referral rates to secondary care renal services. METHODS AND FINDINGS: Individuals with 2 or more Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFR values < 60 ml/min/1.73 m2 more than 90 days apart and a urine ACR or protein-to-creatinine ratio measurement between 1 December 2004 and 1 November 2016 were included in the cohort. The cohort included 35,539 (5.6%) individuals (57.5% female, mean age 75.9 years, median CKD-EPI eGFR 51 ml/min/1.73 m2, median ACR 3.2 mg/mmol) from a total adult practice population of 630,504. Overall, 176 (0.50%) and 429 (1.21%) ESRD events occurred within 2 and 5 years, respectively. Median length of follow-up was 4.7 years (IQR 2.8 to 6.6). Model discrimination was excellent for both 2-year (C-statistic 0.932, 95% CI 0.909 to 0.954) and 5-year (C-statistic 0.924, 95% 0.909 to 0.938) ESRD prediction. The KFRE overpredicted risk in lower (<20%) risk groups. Reducing the model's baseline risk improved calibration for both 2- and 5-year risk for lower risk groups, but led to some underprediction of risk in higher risk groups. Compared to current criteria, using referral criteria based on a KFRE-calculated 5-year ESRD risk of ≥5% and/or an ACR of ≥70 mg/mmol reduced the number of individuals eligible for referral who did not develop ESRD, increased the likelihood of referral eligibility in those who did develop ESRD, and referred the latter at a younger age and with a higher eGFR. The main limitation of the current study is that the cohort is from one region of the UK and therefore may not be representative of primary care CKD care in other countries. CONCLUSIONS: In this cohort, the recalibrated KFRE accurately predicted the risk of ESRD at 2 and 5 years in primary care. Its introduction into primary care for referrals to secondary care renal services may lead to a reduction in unnecessary referrals, and earlier referrals in those who go on to develop ESRD. However, further validation studies in more diverse cohorts of the clinical impact projections and suggested referral criteria are required before the latter can be clinically implemented.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Major RW, Shepherd D, Medcalf JF, et al. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study. PLoS Med. 2019. PMID: 31693662. doi:10.1371/journal.pmed.1002955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。